TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Prostate Cancer Diagnostics Solution Market, Global Outlook and Forecast 2022-2028

Prostate Cancer Diagnostics Solution Market, Global Outlook and Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 05 September 2022
  • Pages :61
  • Formats:
  • Report Code:SMR-7326214
OfferClick for best price

Best Price: $2600

Prostate Cancer Diagnostics Solution Market Size, Share 2022


This report contains market size and forecasts of Prostate Cancer Diagnostics Solution in Global, including the following market information:

Global Prostate Cancer Diagnostics Solution Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Prostate Cancer Diagnostics Solution market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tumor Biomarker Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Prostate Cancer Diagnostics Solution include OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health and DiaSorin, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Prostate Cancer Diagnostics Solution companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Prostate Cancer Diagnostics Solution Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Prostate Cancer Diagnostics Solution Market Segment Percentages, by Type, 2021 (%)

Tumor Biomarker Tests

Imaging

Biopsy

Other

Global Prostate Cancer Diagnostics Solution Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Prostate Cancer Diagnostics Solution Market Segment Percentages, by Application, 2021 (%)

Age Below 55

Age 55-75

Age Above 75

Global Prostate Cancer Diagnostics Solution Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Prostate Cancer Diagnostics Solution Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Prostate Cancer Diagnostics Solution revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Prostate Cancer Diagnostics Solution revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

OPKO

Genomic Health

Abbott

Beckman Coulter

Siemens Healthcare

bioMeriux

Roche

MDx Health

DiaSorin

Myriad Genetics

Ambry Genetics

Report Attributes Report Details
Report Title Prostate Cancer Diagnostics Solution Market, Global Outlook and Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 61 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Diagnostics Solution Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Diagnostics Solution Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Diagnostics Solution Overall Market Size
2.1 Global Prostate Cancer Diagnostics Solution Market Size: 2021 VS 2028
2.2 Global Prostate Cancer Diagnostics Solution Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Diagnostics Solution Players in Global Market
3.2 Top Global Prostate Cancer Diagnostics Solution Companies Ranked by Revenue
3.3 Global Prostate Cancer Diagnostics Solution Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Diagnostics Solution Companies in Global Market, by Revenue in 2021
3.5 Global Companies Prostate Cancer Diagnostics Solution Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Diagnostics Solution Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Diagnostics Solution Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics Solution Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Prostate Cancer Diagnostics Solution Market Size Markets, 2021 & 2028
4.1.2 Tumor Biomarker Tests
4.1.3 Imaging
4.1.4 Biopsy
4.1.5 Other
4.2 By Type - Global Prostate Cancer Diagnostics Solution Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Diagnostics Solution Revenue, 2017-2022
4.2.2 By Type - Global Prostate Cancer Diagnostics Solution Revenue, 2023-2028
4.2.3 By Type - Global Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Diagnostics Solution Market Size, 2021 & 2028
5.1.2 Age Below 55
5.1.3 Age 55-75
5.1.4 Age Above 75
5.2 By Application - Global Prostate Cancer Diagnostics Solution Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Diagnostics Solution Revenue, 2017-2022
5.2.2 By Application - Global Prostate Cancer Diagnostics Solution Revenue, 2023-2028
5.2.3 By Application - Global Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Prostate Cancer Diagnostics Solution Market Size, 2021 & 2028
6.2 By Region - Global Prostate Cancer Diagnostics Solution Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Diagnostics Solution Revenue, 2017-2022
6.2.2 By Region - Global Prostate Cancer Diagnostics Solution Revenue, 2023-2028
6.2.3 By Region - Global Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Prostate Cancer Diagnostics Solution Revenue, 2017-2028
6.3.2 US Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.3.3 Canada Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.3.4 Mexico Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Diagnostics Solution Revenue, 2017-2028
6.4.2 Germany Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.4.3 France Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.4.4 U.K. Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.4.5 Italy Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.4.6 Russia Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.4.7 Nordic Countries Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.4.8 Benelux Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Diagnostics Solution Revenue, 2017-2028
6.5.2 China Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.5.3 Japan Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.5.4 South Korea Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.5.5 Southeast Asia Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.5.6 India Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Prostate Cancer Diagnostics Solution Revenue, 2017-2028
6.6.2 Brazil Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.6.3 Argentina Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Diagnostics Solution Revenue, 2017-2028
6.7.2 Turkey Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.7.3 Israel Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.7.4 Saudi Arabia Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.7.5 UAE Prostate Cancer Diagnostics Solution Market Size, 2017-2028
7 Players Profiles
7.1 OPKO
7.1.1 OPKO Corporate Summary
7.1.2 OPKO Business Overview
7.1.3 OPKO Prostate Cancer Diagnostics Solution Major Product Offerings
7.1.4 OPKO Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
7.1.5 OPKO Key News
7.2 Genomic Health
7.2.1 Genomic Health Corporate Summary
7.2.2 Genomic Health Business Overview
7.2.3 Genomic Health Prostate Cancer Diagnostics Solution Major Product Offerings
7.2.4 Genomic Health Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
7.2.5 Genomic Health Key News
7.3 Abbott
7.3.1 Abbott Corporate Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Prostate Cancer Diagnostics Solution Major Product Offerings
7.3.4 Abbott Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
7.3.5 Abbott Key News
7.4 Beckman Coulter
7.4.1 Beckman Coulter Corporate Summary
7.4.2 Beckman Coulter Business Overview
7.4.3 Beckman Coulter Prostate Cancer Diagnostics Solution Major Product Offerings
7.4.4 Beckman Coulter Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
7.4.5 Beckman Coulter Key News
7.5 Siemens Healthcare
7.5.1 Siemens Healthcare Corporate Summary
7.5.2 Siemens Healthcare Business Overview
7.5.3 Siemens Healthcare Prostate Cancer Diagnostics Solution Major Product Offerings
7.5.4 Siemens Healthcare Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
7.5.5 Siemens Healthcare Key News
7.6 bioMeriux
7.6.1 bioMeriux Corporate Summary
7.6.2 bioMeriux Business Overview
7.6.3 bioMeriux Prostate Cancer Diagnostics Solution Major Product Offerings
7.6.4 bioMeriux Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
7.6.5 bioMeriux Key News
7.7 Roche
7.7.1 Roche Corporate Summary
7.7.2 Roche Business Overview
7.7.3 Roche Prostate Cancer Diagnostics Solution Major Product Offerings
7.7.4 Roche Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
7.7.5 Roche Key News
7.8 MDx Health
7.8.1 MDx Health Corporate Summary
7.8.2 MDx Health Business Overview
7.8.3 MDx Health Prostate Cancer Diagnostics Solution Major Product Offerings
7.8.4 MDx Health Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
7.8.5 MDx Health Key News
7.9 DiaSorin
7.9.1 DiaSorin Corporate Summary
7.9.2 DiaSorin Business Overview
7.9.3 DiaSorin Prostate Cancer Diagnostics Solution Major Product Offerings
7.9.4 DiaSorin Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
7.9.5 DiaSorin Key News
7.10 Myriad Genetics
7.10.1 Myriad Genetics Corporate Summary
7.10.2 Myriad Genetics Business Overview
7.10.3 Myriad Genetics Prostate Cancer Diagnostics Solution Major Product Offerings
7.10.4 Myriad Genetics Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
7.10.5 Myriad Genetics Key News
7.11 Ambry Genetics
7.11.1 Ambry Genetics Corporate Summary
7.11.2 Ambry Genetics Business Overview
7.11.3 Ambry Genetics Prostate Cancer Diagnostics Solution Major Product Offerings
7.11.4 Ambry Genetics Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
7.11.5 Ambry Genetics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES



REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount